12:00 AM
 | 
May 21, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

BGM Galectin-3 heart failure risk test regulatory update

BG Medicine received CE Mark approval to expand the indication for its BGM Galectin-3 heart failure risk test to include use in adults with elevated levels of galectin-3. The company...

Read the full 130 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >